Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Context is key: Understanding the regulation, functional control, and activities of the p53 tumour suppressor.
Journal: Cell biochemistry and function
Published: July 14, 2020
Association of two BRM promoter polymorphisms and smoking status with malignant pleural mesothelioma risk and prognosis.
Journal: Molecular carcinogenesis
Published: February 21, 2019
Novel Mutation Pair L858M/L861Q Caused Resistance to Both First- and Third-Generation EGFR Inhibitors, but Was Found to Be Sensitive to the Combination of Lapatinib and Erbitux.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: June 28, 2017
Two BRM promoter polymorphisms predict poor survival in patients with hepatocellular carcinoma.
Journal: Molecular carcinogenesis
Published: May 26, 2017
Association of BRM promoter polymorphisms and esophageal adenocarcinoma outcome.
Journal: Oncotarget
Published: October 20, 2016
Loss of the SWI/SNF ATPase subunits BRM and BRG1 drives lung cancer development.
Journal: Oncoscience
Published: August 25, 2016
Palliative treatment of patients with inoperable locally advanced, recurrent or metastatic head and neck squamous cell cancer, using a low-dose and personalized chemotherapeutic regimen.
Journal: Oncology letters
Published: August 08, 2016
BRM Promoter Polymorphisms and Survival of Advanced Non-Small Cell Lung Cancer Patients in the Princess Margaret Cohort and CCTG BR.24 Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 07, 2016
BRM polymorphisms, pancreatic cancer risk and survival.
Journal: International journal of cancer
Published: February 01, 2016
Last Updated: 09/26/2026